Quantcast
Channel: WN.com - Articles related to MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and Approval of Share Issuances
Viewing all articles
Browse latest Browse all 300

MELA SCIENCES, INC., A LEADER IN THE FIGHT AGAINST MELANOMA, HOSTS SYMPOSIUM AT 8th WORLD CONGRESS OF MELANOMA (MELA Sciences Inc)

$
0
0
(Source: MELA Sciences Inc) RVINGTON, NY, July 22, 2013 - MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, presented at the 8th World Congress of Melanoma held in Hamburg, Germany, on July 19, 2013 to a well attended room. The symposium, led by Axel Hauschild, MD, PhD, Professor and Head of the Interdisciplinary Skin Cancer Center at the Department of Dermatology, University Hospital Schleswig-Holstein in Kiel, Germany, and by Andreas Blum MD, PhD, Associate Professor of Dermatology at the...

Viewing all articles
Browse latest Browse all 300

Trending Articles